PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 12 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,002,000 | +0.3% | 1,500,000 | 0.0% | 1.10% | +21.9% |
| Q2 2016 | $999,000 | -1.7% | 1,500,000 | 0.0% | 0.90% | -12.9% |
| Q1 2016 | $1,016,000 | -1.6% | 1,500,000 | 0.0% | 1.03% | +17.9% |
| Q4 2015 | $1,032,000 | -44.2% | 1,500,000 | -42.3% | 0.88% | -37.9% |
| Q3 2015 | $1,851,000 | -5.7% | 2,600,000 | 0.0% | 1.41% | +15.8% |
| Q2 2015 | $1,963,000 | +1.2% | 2,600,000 | 0.0% | 1.22% | +26.9% |
| Q1 2015 | $1,940,000 | -1.3% | 2,600,000 | 0.0% | 0.96% | -0.6% |
| Q4 2014 | $1,965,000 | – | 2,600,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 4,000,000 | $3,200,000 | 2.53% |
| Mohican Financial Management, LLC | 2,600,000 | $1,965,000 | 0.97% |
| Camber Capital Management LP | 9,000,000 | $6,904,000 | 0.46% |
| LINDEN ADVISORS LP | 2,000,000 | $1,519,000 | 0.29% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 16,772,000 | $12,674,000 | 0.16% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,000,000 | $8,635,000,000 | 0.15% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,900,000 | $5,442,000 | 0.11% |
| ANGELO GORDON & CO., L.P. | 2,500,000 | $1,889,000 | 0.09% |
| Baker Brothers Advisors | 3,500,000 | $2,645,000 | 0.03% |
| FEDERATED HERMES, INC. | 5,330,000 | $4,040,000 | 0.01% |